S-23 60tab/10mg s-23 – Magnus

Magnus S‑23 is a potent research compound classified as a Selective Androgen Receptor Modulator (SARM). Designed for individuals engaged in advanced performance research, S‑23 offers targeted anabolic effects with a focus on lean muscle mass and bone density. Users report significant strength gains and minimal impact on systemic hormone levels compared to traditional anabolic agents. This product contains 60 tablets of 10mg S-23 each.

S‑23 is a non-steroidal SARM demonstrating high affinity for androgen receptors in muscle and bone tissue. In vitro studies suggest it possesses potent anabolic activity with limited effects on other tissues, reducing the likelihood of typical steroid side effects. It operates by selectively binding to these receptors, promoting protein synthesis and nitrogen retention within target muscles. Users report a noticeable increase in lean body mass and strength without substantial water retention. The compound is orally bioavailable for convenient administration.

Athletes typically run S‑23 cycles to achieve several research goals. Significant Lean Mass Gains: Users report substantial increases in muscle mass with minimal fat gain. Enhanced Bone Density: Research indicates a positive impact on bone mineral density, potentially mitigating risk of injury. Improved Strength & Power Output: S-23 may lead to noticeable strength gains and increased power production. Reduced Muscle Wastage: Users report it can help preserve muscle mass during caloric restriction. However, these effects are not guaranteed.

While S-23 can be utilized as a standalone compound for research purposes, some athletes explore stacking protocols to potentially enhance results. Common pairings include other SARMs like MK-677 (for synergistic growth hormone release) or LGD-4033 (for increased muscle mass). However, combining compounds increases complexity and potential side effects. Researchers often combine S‑23 with peptides such as BPC-157 to support recovery and joint health. Always prioritize individual response and monitoring when stacking compounds.

S‑23 research requires careful consideration of potential side effects. Hepatotoxicity: Prolonged or high-dose use may impact liver function – regular blood work is essential. Androgenic Effects: While selective, some users report mild androgenic side effects like increased aggression or acne. Suppression: S‑23 can suppress natural testosterone production; a Post Cycle Therapy (PCT) protocol is typically recommended following cycle completion. Age 21+ only. This compound is intended for advanced researchers with prior experience.

Users report that S‑23 cycles are typically run in durations of 6-12 weeks, followed by a comprehensive Post Cycle Therapy (PCT) protocol. Athletes typically start with lower doses to assess individual tolerance and gradually increase as needed. Careful monitoring of blood work is crucial throughout the cycle to evaluate liver function and hormonal response.

⚠️ Safety

• Prolonged use without breaks may increase risk of hepatotoxicity – limit cycles to 12 weeks.
• S-23 can significantly suppress natural testosterone production, necessitating PCT.
• Not for use by individuals under the age of 21 or those with pre-existing medical conditions.